CIK 0001661998
- Non-accelerated filer
- Smaller reporting company
Q32 Bio Inc.
Sign in to watch- Ticker
- QTTB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473468154
- Phone
- +1 781-999-0232
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Former names
- Q32 Bio Inc., Homology Medicines, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $320,396
- in 6 filings
Net −$320,396. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-07-01 | Smith W Bradford CFO, Treasurer & Secretary | Sale | −6,000 | $19.00 | $114K | 0 |
| 2019-07-01 | Smith W Bradford CFO, Treasurer & Secretary | Exercise or conversion · Employee Stock Option | −6,000 | 151,404 | ||
| 2019-07-01 | TZIANABOS ARTHUR President & CEO | Sale | −12,500 | $18.98 | $237K | 165,005 |
| 2019-06-06 | Flynn James E Director | Grant or award · Stock Option (Right to Buy) | +15,580 | 15,580 | ||
| 2019-06-06 | Wheeler Cameron Director | Grant or award · Option (Right to Buy) | +15,580 | 15,580 | ||
| 2019-06-06 | Gregory Richard J. Director | Grant or award · Option (Right to Buy) | +15,580 | 15,580 | ||
| 2019-06-06 | Wheeler Cameron Director | Grant or award · Option (Right to Buy) | +15,580 | 15,580 | ||
| 2019-06-06 | Thistle Mary Director | Grant or award · Option (Right to Buy) | +15,580 | 15,580 | ||
| 2019-06-06 | Patterson Matthew R Director | Grant or award · Option (Right to Buy) | +15,580 | 15,580 | ||
| 2019-06-06 | PARMAR KUSH Director | Grant or award · Option (Right to Buy) | +15,580 | 15,580 | ||
| 2019-06-06 | GILLIS STEVEN Director | Grant or award · Option (Right to Buy) | +15,580 | 15,580 | ||
| 2019-06-03 | Smith W Bradford CFO, Treasurer & Secretary | Exercise or conversion | +6,000 | $0.64 | $4K | 6,000 |
| 2019-06-03 | Smith W Bradford CFO, Treasurer & Secretary | Sale | −6,000 | $19.94 | $120K | 0 |
| 2019-06-03 | Smith W Bradford CFO, Treasurer & Secretary | Exercise or conversion · Employee Stock Option | −6,000 | 157,404 | ||
| 2019-06-03 | Kelly Timothy P | Sale | −1,288 | $20.00 | $26K | 0 |
| 2019-06-03 | Seymour Albert Chief Scientific Officer | Sale | −9,300 | $19.90 | $185K | 218,950 |
| 2019-06-03 | TZIANABOS ARTHUR President & CEO | Sale | −12,500 | $19.86 | $248K | 177,505 |
| 2019-06-03 | Rasty Siyamak Chief Operating Officer | Sale | −8,000 | $20.22 | $162K | 230,707 |
| 2019-05-21 | ARCH Venture Fund VIII, L.P. 10% owner | Other disposition | −300,001 | 5,768,694 | ||
| 2019-05-16 | 5AM Ventures IV, L.P. 10% owner | Sale | −590,400 | $21.47 | $12.7M | 5,314,484 |
Page 21 of 25 · 492 trades